Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Collaboration revenue $ 18,626 $ 37,255
Operating expenses:    
Research and development 644,042 3,745,940
General and administrative 653,455 1,903,709
Total operating expenses 1,297,497 5,649,649
Loss from operations (1,278,871) (5,612,394)
Foreign exchange gain 110,362 70,252
Net loss $ (1,168,509) $ (5,542,142)
Per share information:    
Net loss per share, basic $ (0.31) $ (17.62)
Net loss per share, diluted $ (0.31) $ (17.62)
Weighted average shares outstanding, basic 3,797,753 314,472
Weighted average shares outstanding, diluted 3,797,753 314,472